Weight Loss Medication on the NHS

We are receiving enquiries from patients about the prescribing of weight loss medication, specifically Tirzepatide (Mounjaro), which was approved by NICE for use on the NHS recently.
For the next year, only those patients who meet specific eligibility criteria will have access (those with BMI over 40 and 4 or more ‘qualifying’ comorbitidies. BMI for non-Caucasian background may be slightly lower).

Those who are eligible according to our records will be contacted. If you believe you qualify we would need an up-to-date weight reading to consider if we are able to prescribe.